Conclusion

Millions of people suffer from allergic diseases. In France comprise 800 000 patients with allergic diseases. Almost half of them suffer severe bronchial asthma and 200 000-eczema.
In England, the incidence of allergic diseases as high as in France; in this country there annually 10 000 000 days of incapacity due to allergic diseases. Thus, allergic diseases represent an important social problem.
It should be noted that allergic diseases in contrast to many other chronic diseases begin at a young age.
A child suffering from asthma and eczema, deprived of many joys in childhood and later life. About his physical and moral suffering throughout life only know his family and the attending physician.
Deaths for insect bites or the introduction of allergic medicine currently, there.
Severe asthmatic condition, lasting 3-4 days, also can result in death of the patient. Of course, in comparison with the number of patients with allergic diseases, the mortality rate from them small. In old age, the severity of allergic manifestations increases due to the accession of complications from which the patient suffers.
In bronchial asthma repeated respiratory tract infections cause obstructive pulmonary emphysema. Infection, and also intensify sensitisation of the body: for example, with repeated respiratory tract infections allergic rhinopathy turns into hyperplastic sinuitis, which is virtually untreatable.
The best method of treatment of allergic diseases is complete cessation of contact with identified allergen. If contact with the allergen to stop impossible, you should use active specific and non-specific therapy that for 50 years has made great progress compared with the treatment of diseases such as infectious nonspecific polyarthritis and vascular diseases.
Allergic tests can identify specific allergen for many allergic diseases of the skin and the respiratory tract. Specific hyposensitization gives a good therapeutic effect. The use of glucocorticoids gave medicine powerful weapon in the fight against severe autoimmune diseases previously considered incurable. Reasonable use of these drugs in severe allergic diseases throughout the life of the patient allows you to return "in order" many of the patients that were previously considered hopeless.
The last word science in Allergology yet. Currently, research is being conducted for the study of substances that may inhibit the biosynthesis of histamine and accelerate its destruction. The application of depot-allergens can reduce the number of injections as a specific giposencibilization patient.
Interest cases of spontaneous cure some of allergic diseases, when clinical symptoms disappear for no apparent reason or in acute infectious disease. The mechanism of these spontaneous remissions or full recovery is not yet understood.
Currently, the progress achieved in the treatment of many allergic diseases, and this allows for an optimistic look into the future.

Literature
Feinberg S. M. Allergy in Practice. The Year Book Publ. Inc. Chicago, 1946.
Gell P. G. H., R. Coombs A. A. Clinical aspects of allergy. Blackwell scientific publ. Oxford, 1963.
Landsteiner K. The specificity of serological reactions. Harvard University Press, 1947. Pasteur Vallery-Radot, Wolfromm P., Charpin J. B. Halpern Maladies allergiques. Flammarlon. Paris, 1964.